ArticleScientific reports2025
Identifying breast cancer risk factors and evaluating biennial mammography screening efficacy using big data analysis in Taiwan.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cost-effectiveness of genetic risk-stratified screening for breast cancer in Taiwan.Breast (Edinburgh, Scotland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Most evidence and experience with mammography screening originate from Western countries, and the optimal prevention strategy for Taiwanese women remains uncertain. Currently, breast cancer susceptibility in Taiwan is primarily stratified by family history, which contrasts with the trend toward personalized screening. Additionally, the high false-positive and false-negative rates (and the resulting compromised positive predictive value) have hindered the widespread adoption of mammography among the general population. Consequently, there is an unmet need to identify breast cancer risk factors to develop a more efficient and tailored screening strategy that minimizes potential harm. This study aimed to identify breast cancer risk factors by analyzing big data, including National Health Insurance claims data, a screening database, a cancer registry from the Health Promotion Administration, and a death registry from census data. Between 2007 and 2017, 189,465 entries were extracted from the cancer registry, representing 133,546 breast cancer cases. The screening database contained 3,806,128 mammography episodes from 2004 to 2014. We identified subjects who had attended at least one screening session between January 2007 and September 2014, matching cancer cases to the registry. Screening intervals were extended by two years to August 2016. After excluding patients with pre-existing breast malignancies, 3,605,758 screening mammography episodes from 2,191,742 invitees were analyzed, resulting in the identification of 38,815 incident breast cancer cases. Multivariate analyses revealed that risk factors for breast cancer diagnosis included a family history of any cancer (odds ratio [OR]: 1.462), number of sisters with breast cancer (OR: 1.058), years of hormone replacement therapy (OR: 1.006), breast symptoms (OR: 3.843), breast examinations within two years (OR: 1.226), prior breast surgery (OR: 1.044), educational level (OR: 1.04), and breast density (OR: 1.096). Protective factors included menopausal status (OR: 0.935), breastfeeding (OR: 0.908), sonography within two years (OR: 0.899), comparison with prior mammography (OR: 0.775), number of mammography screenings (OR: 0.673), and screening via a mobile van (OR: 0.587). The model demonstrated an area under the receiver operating characteristic curve (AUC) of 0.6766. Among 50,831 breast cancer cases, 47.6% had undergone at least one mammography screening before diagnosis, which was associated with earlier disease stages. Clinically detected breast cancer was an independent risk factor for recurrence-free and overall survival, as well as breast cancer mortality. Big data analysis identified several risk factors for breast cancer development in Taiwanese women and confirmed the efficacy of mammography screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.